“I tested it three or four times before I believed it,” said Shigenori Inagaki of the discovery that enabled the breakthrough.

Albumin replacement therapy targeting serum levels ≥ 3.0 g/dL does not improve 90-day survival in patients with septic shock in the emergency department, a trial shows.

A retrospective cohort study in Veterans with cirrhosis found that giving intravenous albumin after outpatient paracentesis ...

The vasoconstrictor terlipressin is used for type 1 hepatorenal syndrome (HRS-1) in many parts of the world and is part of the clinical practice guidelines in Europe. We conducted a phase 3 trial to ...

The appropriateness of albumin use and baseline albumin usage patterns were studied. Institutional practice patterns regarding the use of albumin were compared to criteria established by an ...

Cooking pros share how to avoid the white stuff that can seep out of cooked salmon, so your fish can look as good as it tastes.

It remains uncertain whether the choice of resuscitation fluid for patients in intensive care units (ICUs) affects survival. We conducted a multicenter, randomized, double-blind trial to compare the ...

New York, United States, Jan. 23, 2024 (GLOBE NEWSWIRE) -- The Global Albumin Market Size is to Grow from USD 6.1 Billion in 2022 to USD 9.6 Billion by 2032, at a Compound Annual Growth Rate (CAGR) of ...